Novartis Strikes Kymriah Outcome-Based Deal With German Insurers
Novartis and German insurers have agreed a payment by outcomes deal for its CAR-T therapy Kymriah.

Novartis and German insurers have agreed a payment by outcomes deal for its CAR-T therapy Kymriah.